Prostate-specific antigen spikes after permanent prostate brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 54, Issue 2, 2002, Pages 450-456

  Merrick, Gregory S ^a   Butler, Wayne M ^a,b   Wallner, Kent E ^c   Galbreath, Robert W ^d   Anderson, Richard L ^a  

^a WHEELING HOSPITAL   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c Puget Sound Health Care System   (United States)

^d WHEELING JESUIT UNIVERSITY   (United States)

Author keywords

103Pd; 125I; Brachytherapy; Prostate cancer; Prostate specific antigen

Indexed keywords

ANTIGENS; BIOCHEMISTRY; BIOPSY; DOSIMETRY; HORMONES; ISOTOPES; RADIOTHERAPY; REGRESSION ANALYSIS;

CLINICAL FAILURES;

ONCOLOGY;

IODINE 125; PALLADIUM; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; BIOPSY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROSTATE; PROSTATE ADENOCARCINOMA; RADIATION DOSE; SEMINAL VESICLE;

ADENOCARCINOMA; AGED; ANALYSIS OF VARIANCE; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS;

EID: 0036805255     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02948-6     Document Type: Article

References (21)

1. Merrick G.S., Butler W.M., Lief J.H., et al. Is brachytherapy comparable with radical prostatectomy and external beam radiation therapy for clinically localized prostate cancer? Tech Urol. 7:2001;12-19.
2. American Society for Therapeutic Radiation and Oncology Consensus Panel . Consensus statement Guidelines for PSA following radiation therapy . Int J Radiat Oncol Biol Phys. 37:1997;1035-1041.
3. Hanlon A.L., Moore D.F., Hanks G.E. Modeling postradiation prostate specific antigen level kinetics Predictors of rising postnadir slope suggest cure in men who remain biochemically free of prostate carcinoma . Cancer. 83:1998;130-134.
4. Zagars G.K., Pollack A. Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer. Radiother Oncol. 44:1997;213-221.
5. Wallner K.E., Blasko J., Dattoli M.J. Evaluating cancer status. Wallner K.E., Blasko J., Dattoli M.J., Prostate brachytherapy made complicated. 1997;14-14.15 SmartMedicine Press, Seattle.
6. Cavanagh W., Blasko J.C., Grimm P.D., et al. Transient elevation of serum prostate-specific antigen following I-125/Pd-103 brachytherapy for localized prostate cancer. Semin Urol Oncol. 18:2000;160-165.
7. Critz F.A., Williams W.H., Benton J.B., et al. Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer. J Urol. 163:2000;1085-1089.
8. Smathers S., Wallner K., Sprouse J., et al. Temporary PSA rises and repeat prostate biopsies after brachytherapy. Int J Radiat Oncol Biol Phys. 50:2001;1207-1211.
9. Merrick G.S., Butler W.M., Farthing W.H., et al. The impact of Gleason score accuracy as a criterion for prostate brachytherapy patient selection. J Brachyther Int. 14:1998;113-121.
10. Nath R., Anderson L.L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 . Med Phys. 22:1995;209-243.
11. Merrick G.S., Butler W.M. Modified uniform seed loading for prostate brachytherapy Rationale, design, and evaluation . Tech Urol. 6:2000;78-84.
12. Butler W.M., Merrick G.S., Lief J.H., et al. Comparison of seed loading approaches in prostate brachytherapy. Med Phys. 27:2000;381-392.
13. Merrick G.S., Butler W.M., Dorsey A.T., et al. Potential role of various dosimetric quality indicators in prostate brachytherapy. Int J Radiat Oncol Biol Phys. 44:1999;717-724.
14. Merrick G.S., Butler W.M., Dorsey A.T., et al. The effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation. Tech Urol. 7:2001;233-240.
15. Merrick G.S., Butler W.M., Dorsey A.T., et al. Seed fixity in the prostate/periprostatic region following brachytherapy. Int J Radiat Oncol Biol Phys. 46:2000;215-220.
16. Merrick GS, Butler WM, Wallner KE; et al. Extracapsular radiation dose distribution following permanent prostate brachytherapy. Int J Cancer (Radiat Oncol Invest). In press.
17. Butler W.M., Merrick G.S., Dorsey A.T., et al. Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy. Int J Radiat Oncol Biol Phys. 48:2000;1575-1582.
18. Hanlon A.L., Pinover W.H., Horwitz E.M., et al. Patterns and fate of PSA bouncing following 3D-CRT. Int J Radiat Oncol Biol Phys. 50:2001;1207-1211.
19. Prestidge B.R., Hoak D.C., Grimm P.D., et al. Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer. Int J Radiat Oncol Biol Phys. 37:1997;31-39.
20. Crook J.M., Perry G.A., Robertson S., et al. Routine prostate biopsies following radiotherapy for prostate cancer Results for 226 patients . Urology. 45:1995;624-632.
21. Kuban D.A., El-Mahdi A.M., Schellhammer P. The significance of post-irradiation prostate biopsy with long-term follow-up. Int J Radiat Oncol Biol Phys. 24:1992;409-414.